Kenya Pharma

Presidential Initiative:
U.S. Global Health Initiative

Funding Level:
$550 million

Duration:
July 2009 – July 2014

Activity Goals:

  • Quantify existing stocks and consumption patterns and develop forecasting and quantification processes
  • Strengthen collaboration between the U.S. President's Emergency Plan for AIDS Relief and the Kenyan government supply chains to improve forecasting accuracy and avoid stockouts and rationing

Activity Accomplishments:

  • Supplied HIV commodities that reach more than 352,000 patients countrywide
  • Procured HIV/AIDS commodities that reached 687 Antiretroviral Therapy sites

Key Partners:
Ministry of Health, the National AIDS and Sexually Transmitted Disease Control Program, and Kenya Medical Supplies Agency

Activity Locations:
Nationwide


ACTIVITY OVERVIEW

The Kenya Pharma activity applies innovative approaches to increase the scale and efficiency of HIV/AIDS care, prevention, and treatment. It works in close collaboration with the Government of Kenya and the National AIDS and Sexually Transmitted Disease Control Program. Kenya Pharma provides an uninterrupted supply of high-quality, low-cost medical commodities to people living with HIV/AIDS through a drug procurement and distribution system.

ACTIVITY AREAS

Kenya Pharma empowers health care workers to provide first-rate care to patients through a reliable supply chain—from forecasting and quantification, to delivery to health clinics, hospitals and other service points. It ensures that the commodities procured are of high-quality and are stored in proper conditions.

Kenya Pharma:

  • Quantifies the ARVs and OI drugs needed to meet USG country targets
  • Procures the required pharmaceuticals and other commodities
  • Ensures proper storage of PEPFAR commodities
  • Distributes pharmaceuticals in a timely and efficient manner to ensure continuity in patient treatment
  • Performs regular quality assurance reviews of the commodities procured through recognized quality control laboratories
  • Maintains records on stocks for monitoring and evaluation of the project

ACTIVITY IMPACT

On March 4, 2013, Kenya’s general election was held. This was the first general election under the new Constitution and the first election subsequent to the general election of 2007, which resulted in incidents of post-election violence and disruption. While it was hoped that this election period would be peaceful and much effort was devoted to ensuring that peace. Many organizations, including Kenya Pharma, put in place contingency plans to ensure the continuity of critical HIV/AIDS supplies in the event that the peace did not hold.

“Kenya Pharma’s approach was to take into consideration everything from the logistics of storage, to transportation, right down to the facility level in terms of: do we have the nurses there, is the task shifting going on, who is going to be responsible for actually writing down who is receiving what? We must get down to those sorts of levels and I thought that was a real strength of Kenya Pharma. In the election contingency plan, Kenya Pharma had walked an extra mile and that is very good,” said Gary Jones, security & humanitarian response advisor, UNAIDS.
 

“Kenya Pharma’s approach was to take into consideration everything from the logistics of storage, to transportation, right down to the facility level in terms of: do we have the nurses there, is the task shifting going on, who is going to be responsible for actually writing down who is receiving what? We must get down to those sorts of levels and I thought that was a real strength of Kenya Pharma. In the election contingency plan, Kenya Pharma had walked an extra mile and that is very good,” said Gary Jones, security & humanitarian response advisor, UNAIDS.

Thankfully for the entire country, peace generally prevailed, and there were virtually no disruptions in service or supply.


USAID Contact:
James Batuka, Activity Manager
USAID/Kenya
Tel: 254 0721-360138
Email: jbatuka@usaid.gov

Kenya Pharma Contact:
Steve Hawkins
Kenya Pharma Project Director
Chemonics International, Inc.
Tel:  +254 738 117 242
Email: shawkins@kenyapharma.org

Website:  
www.kenyapharma.org

Chemonics International Inc.
www.chemonics.com
DHL Kenya
Mission for Essential Drugs and Supplies
National Quality Control Laboratory
Phillips Healthcare Services Limited
Vimta Labs
 

Updated January 2014

Last updated: August 06, 2014

Share This Page